- Home
- PLUR vs ENLV Comparison
PLUR vs ENLV Comparison
Compare PLUR & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- ENLV
- Stock Information
- Founded
- PLUR 2001
- ENLV 2005
- Country
- PLUR Israel
- ENLV Israel
- Employees
- PLUR N/A
- ENLV N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- PLUR Health Care
- ENLV Health Care
- Exchange
- PLUR Nasdaq
- ENLV Nasdaq
- Market Cap
- PLUR 24.9M
- ENLV 23.7M
- IPO Year
- PLUR N/A
- ENLV 1995
- Fundamental
- Price
- PLUR $4.66
- ENLV $1.16
- Analyst Decision
- PLUR
- ENLV Strong Buy
- Analyst Count
- PLUR 0
- ENLV 2
- Target Price
- PLUR N/A
- ENLV $9.50
- AVG Volume (30 Days)
- PLUR 7.6K
- ENLV 206.7K
- Earning Date
- PLUR 02-11-2025
- ENLV 03-28-2025
- Dividend Yield
- PLUR N/A
- ENLV N/A
- EPS Growth
- PLUR N/A
- ENLV N/A
- EPS
- PLUR N/A
- ENLV N/A
- Revenue
- PLUR $678,000.00
- ENLV N/A
- Revenue This Year
- PLUR N/A
- ENLV N/A
- Revenue Next Year
- PLUR N/A
- ENLV N/A
- P/E Ratio
- PLUR N/A
- ENLV N/A
- Revenue Growth
- PLUR 89.92
- ENLV N/A
- 52 Week Low
- PLUR $4.07
- ENLV $0.81
- 52 Week High
- PLUR $8.48
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- PLUR 53.72
- ENLV 56.90
- Support Level
- PLUR $4.25
- ENLV $1.02
- Resistance Level
- PLUR $4.90
- ENLV $1.29
- Average True Range (ATR)
- PLUR 0.20
- ENLV 0.11
- MACD
- PLUR 0.03
- ENLV 0.02
- Stochastic Oscillator
- PLUR 51.35
- ENLV 65.78
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.